Profile
Kenneth M.
Bahrt worked as an Executive Director-Global Medical Affairs at Bristol Myers Squibb Co. from 2004 to 2007, as a Medical Director at Pfizer Inc. from 2000 to 2004, as a Global Medical Director at Hoffman-LaRoche F & Co. AG from 2007 to 2009, as the Head-Immunology Medical Affairs at Genentech, Inc. from 2009 to 2011, as the Chief Medical Officer & Senior Vice President at Savient Pharmaceuticals, Inc. from 2012 to 2014, as the Vice President-US Medical Affairs at NPS Pharmaceuticals, Inc. from 2014 to 2015, and as the Chief Medical Officer at Outlook Therapeutics, Inc. from 2015 to 2019.
Bahrt received his undergraduate degree from Muhlenberg College and his doctorate from Hahnemann University.
Former positions of Kenneth Bahrt
| Companies | Position | End |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-04-22 |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-04-30 |
| SAVIENT PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2011-07-31 |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Chief Tech/Sci/R&D Officer | 2009-08-31 |
Training of Kenneth Bahrt
| Muhlenberg College | Undergraduate Degree |
| Hahnemann University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| OUTLOOK THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
- Stock Market
- Insiders
- Kenneth Bahrt
